Prime Medicine, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2021 | — | $-85.3M | — |
| Jun 2021 | — | $-78.4M | — |
| Sep 2021 | — | $-94.4M | $200.7M |
| Dec 2021 | — | $-156.2M | $185.4M |
| Mar 2022 | — | $-166.9M | $164.2M |
| Jun 2022 | — | $-195.1M | $92.2M |
| Sep 2022 | — | $-223.1M | $47.9M |
| Dec 2022 | — | $316.3M | $187.6M |
| Mar 2023 | — | $278.8M | $133.5M |
| Jun 2023 | — | $240.1M | $120.6M |
| Sep 2023 | — | $194.0M | $44.0M |
| Dec 2023 | — | $133.1M | $41.6M |
| Mar 2024 | — | $243.8M | $94.2M |
| Jun 2024 | — | $196.6M | $55.6M |
| Sep 2024 | — | $189.5M | $118.0M |
| Dec 2024 | — | $153.1M | $182.5M |
| Mar 2025 | — | $106.9M | $91.9M |
| Jun 2025 | — | $60.9M | $53.8M |
| Sep 2025 | — | $161.8M | $71.4M |
| Dec 2025 | — | $120.9M | $63.0M |